These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32643099)

  • 1. Medulloblastoma: an Old Diagnosis with New Promises.
    Szalontay L; Khakoo Y
    Curr Oncol Rep; 2020 Jul; 22(9):90. PubMed ID: 32643099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
    Menyhárt O; Győrffy B
    Cancer Metastasis Rev; 2020 Mar; 39(1):211-233. PubMed ID: 31970590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
    Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Approaches in Targeted Therapy for Medulloblastoma in Children.
    Maier H; Dalianis T; Kostopoulou ON
    Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of the management of pediatric and adult medulloblastoma].
    Vigneron C; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Helfre S; Alapetite C; Coca A; Kehrli P; Noël G
    Cancer Radiother; 2015 Aug; 19(5):347-57; quiz 358-9, 362. PubMed ID: 26141663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medulloblastoma: From Myth to Molecular.
    Ramaswamy V; Taylor MD
    J Clin Oncol; 2017 Jul; 35(21):2355-2363. PubMed ID: 28640708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood medulloblastoma: progress and future challenges.
    Packer RJ
    Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
    Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEOM clinical guideline for management of adult medulloblastoma (2020).
    Luque R; Benavides M; Del Barco S; Egaña L; García-Gómez J; Martínez-García M; Pérez-Segura P; Pineda E; Sepúlveda JM; Vieito M
    Clin Transl Oncol; 2021 May; 23(5):940-947. PubMed ID: 33792841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma in Older Adults: A Case Report and Literature Review.
    Murase M; Saito K; Abiko T; Yoshida K; Tomita H
    World Neurosurg; 2018 Sep; 117():25-31. PubMed ID: 29883827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma.
    Bagchi A; Dhanda SK; Dunphy P; Sioson E; Robinson GW
    J Natl Compr Canc Netw; 2023 Aug; 21(10):1097-1105. PubMed ID: 37643637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we treat medulloblastoma in adults.
    Franceschi E; Seidel C; Sahm F; Pajtler KW; Hau P
    ESMO Open; 2021 Aug; 6(4):100173. PubMed ID: 34118771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma molecular dissection: the way toward targeted therapy.
    Remke M; Ramaswamy V; Taylor MD
    Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-stratification for treatment de-intensification in WNT-pathway medulloblastoma: finding the optimal balance between survival and quality of survivorship.
    Gupta T; Mani S; Chatterjee A; Dasgupta A; Epari S; Chinnaswamy G
    Expert Rev Anticancer Ther; 2024 Jul; 24(7):589-598. PubMed ID: 38761170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
    Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
    Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups.
    Eid AM; Heabah NAE
    J Egypt Natl Canc Inst; 2021 Feb; 33(1):6. PubMed ID: 33555447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.
    Lhermitte B; Blandin AF; Coca A; Guerin E; Durand A; Entz-Werlé N
    Neurochirurgie; 2021 Feb; 67(1):39-45. PubMed ID: 29776650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.